Featured patents

Bioadhesive Progressive Hydration Tablets
US 08765177 B2, July 1, 2014, Dominique De Ziegler et al. / Columbia Laboratories, Inc. (Boston, US)
A bioadhesive controlled, sustained release progressive hydration pharmaceutical…

Clonidine Formulation
US 08623409 B1, Jan. 7, 2014, Yu-Hsing Tu et al. / Tris Pharma Inc. (Monmouth Junction, US)
An oral clonidine liquid suspension composition having a twenty-four hour…

Combination Tablet With Chewable Outer Layer
US 08652520 B2, Feb. 18, 2014, Joseph Peter Habboushe / Vitalis LLC (Wilmington, US)
A tablet comprising: (a)…

Compositions for the Oral Delivery of Corticosteroids
US 08491932 B2, July 23, 2013, Ann Margaret Dyer et al. / Archimedes Development Limited (Nottingham, GB)
An oral drug delivery composition for providing sustained release of budesonide…

Controlled Release Compositions Containing Zolpidem
US 08846084 B2, Sept. 30, 2014, Venkatesh Madhavacharya Joshi et al. / Wockhardt Ltd (Bandra-Kurla Complex, Bandra East, Mumbai, IN)
A dry granulated pharmaceutical dosage form comprising a polymer matrix, wherein…

Controlled Release Formulation of Erythromycin Derivatives
US 08507000 B2, Aug. 13, 2013, Nirmal Mulye / Nostrum Pharmaceuticals, Inc. (Kendall Park, US)
A controlled release formulation in tablet form comprising a composition…

Controlled Release Formulations and Associated Methods
US 08765178 B2, July 1, 2014, Teshome Melaku et al. / Watson Laboratories, Inc. (Salt Lake City, US)
A sustained release oral dosage pharmaceutical tablet, comprising:…

Controlled Release Metformin Formulations
US 08475841 B2, July 2, 2013, Chih-Ming Chen et al. / Andrx Labs, LLC (Davie, US)
A method of treating a human diabetic patient with an oral solid sustained…

Controlled Release System and Method for Manufacturing the Same
US 08512748 B2, Aug. 20, 2013, Florian Sommer et al. / Boehringer Ingelheim International GmbH (Ingelheim, DE)
A pharmaceutical controlled release system for administration of active…

Controlled-Release Formulations, Method of Manufacture, and Use Thereof
US 08632805 B2, Jan. 21, 2014, Gandha V. Naringrekar et al. / Mutual Pharmaceutical Company, Inc. (Philadelphia, US)
A controlled-release composition, comprising:…

Controlled-Release Pharmaceutical Tablets
US 08703191 B2, April 22, 2014, Horst G. Zerbe et al. / Intelgenx Corp. (Quebec, CA)
A controlled-release pharmaceutical tablet comprising:…

Dosage Form Containing (S)-Pantoprazole as Active Ingredient
US 08758817 B2, June 24, 2014, Rango Dietrich et al. / Takeda GmbH (Constance, DE)
A dosage form for oral administration in tablet form consisting of:…

Dosage Form Containing Pantoprazole as Active Ingredient
US 08703192 B2, April 22, 2014, Sabine Schaefer-Preuss et al. / Takeda GmbH (Constance, DE)
A dosage form for oral administration in tablet form consisting of:…

Extended Release Compositions Comprising as Active Compound Venlafaxine Hydrochloride
US 08557282 B2, Oct. 15, 2013, Yoram Sela / Lycored Bio Ltd. (Yavne, IL)
A pH-independent extended release dosage form having specified dissolution…

Extended Release Dosage Form
US 08524277 B2, Sept. 3, 2013, Shu Li et al. / Alza Corporation (Vacaville, US)
A therapeutic solid, sustained-release composition comprising 1 mg to 1000 mg…

Extended Release Formulation of Nevirapine
US 08460704 B2, June 11, 2013, Michael L. Cappola et al. / Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
A method for treating HIV-1 infection which comprises once daily adminstration…

Extended Release Pellet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof
US 08715728 B2, May 6, 2014, Rolf-Stefan Brickl et al. / Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
An extended release pellet formulation comprising:…

Extended Release Tablet Formulations of Flibanserin and Method for Manufacturing the Same
US 08658207 B2, Feb. 25, 2014, Thomas Friedl et al. / Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
A pharmaceutical release system comprising:…

Extended Release Tablet Formulations of Flibanserin and Method for Manufacturing the Same
US 08545886 B2, Oct. 1, 2013, Wolfram Eisenreich et al. / Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
A pharmaceutical extended release system for an active substance…

Medicinal Composition
US 08703189 B2, April 22, 2014, Yuso Tomohira / Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP)
A medicinal composition consisting essentially of a pharmacologically active…

Methods and Composition of Extended Delivery of Water Insoluble Drugs
US 08535716 B2, Sept. 17, 2013, Paul Kijek et al. / TSRL, Inc. (Ann Arbor, US)
A pharmaceutical composition comprising:…

Modified Release Compositions Comprising Tacrolimus
US 08617599 B2, Dec. 31, 2013, Per Holm et al. / Veloxis Pharmaceuticals A/S (Horsholm, DK)
An oral extended release pharmaceutical composition comprising a therapeutically…

Modified Release Compositions Comprising Tacrolimus
US 08623410 B2, Jan. 7, 2014, Per Holm et al. / Veloxis Pharmaceuticals A/S (Horsholm, DK)
A solid oral extended release pharmaceutical composition comprising (i)…

Modified Release Compositions Comprising Tacrolimus
US 08623411 B2, Jan. 7, 2014, Per Holm et al. / Veloxis Pharmaceuticals A/S (Horsholm, DK)
A method for suppressing a rejection reaction by transplantation of an organ…

Modified Release Compositions Comprising Tacrolimus
US 08586084 B2, Nov. 19, 2013, Per Holm et al. / Veloxis Pharmaceuticals A/S (Hørsholm, DK)
A method for suppressing a rejection reaction by transplantation of an organ…

Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof
US 08617600 B2, Dec. 31, 2013, Kevin Edwards et al. / Supernus Pharmaceuticals, Inc. (Rockville, US)
A solid oral pharmaceutical formulation for once-a-day administration…

Once Daily Formulations of Tetracyclines
US 08709478 B2, April 29, 2014, Rong-Kun Chang et al. / Supernus Pharmaceuticals, Inc. (Rockville, US)
A method for treating rosacea in a mammal in need thereof, comprising…

Oral Tablet Compositions of Dexlansoprazole
US 08758818 B2, June 24, 2014, Levent Oner et al. / Sanovel Ilac Sanayi ve Ticaret Anonim Sirketi (Istanbul, TR)
A dual release oral tablet of at least one of dexlansoprazole, pharmaceutically…

Oral Tablet Compositions of Dexlansoprazole
US 08563035 B2, Oct. 22, 2013, Levent Oner et al.
An oral tablet of at least one of dexlansoprazole, pharmaceutically acceptable…

Pharmaceutical Compositions and Methods for the Treatment of Prostate Cancer
US 08722088 B2, May 13, 2014, Per Cantor et al. / Ferring International Center S.A. (Saint-Prex, CH)
A composition comprising degarelix or pharmaceutically acceptable salt thereof,…

Patentorg has 53 documents under Sustained or Differential Release Type Patents.

Other subcategories for category Drug, bio-affecting and body treating compositions
Quick navigation
New documents
  • Process for the Production of the Actinobacillus Pleuropneumoniae Toxins APXI or APXIII in a Liquid Culture Medium Under Supply of Air Enriched in Carbon Dioxide
  • Method for Manufacturing Nonvolatile Memory Device
  • Supply Chain Demand Satisfaction
  • Supply-Line Management Device
  • Storage Control Device and Method for Managing Snapshot